{
    "organizations": [],
    "uuid": "11df0b9fec6d693d61ed9be6eb0c72931e286daa",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-avadel-pharmaceuticals-reports-q4/brief-avadel-pharmaceuticals-reports-q4-adjusted-loss-per-share-0-28-idUSASB0C9F3",
    "ord_in_thread": 0,
    "title": "BRIEF-Avadel Pharmaceuticals Reports Q4 Adjusted Loss Per Share $0.28",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Avadel Pharmaceuticals Plc:\n* AVADEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS\n* SEES FY 2018 REVENUE $105 MILLION TO $125 MILLION * Q4 EARNINGS PER SHARE VIEW $-0.31, REVENUE VIEW $34.1 MILLION â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T20:38:00.000+02:00",
    "crawled": "2018-03-09T14:51:54.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "avadel",
        "pharmaceutical",
        "plc",
        "avadel",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "result",
        "see",
        "fy",
        "revenue",
        "million",
        "million",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}